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Abstract 
Aim: To ascertain the levels and mechanisms of funding public health in Europe. 
Methods: A review of published and unpublished documents and expenditure data. 
Results: Expenditure on public health in Europe is difficult to determine, but data from 
national health accounts suggest that it differs greatly across countries, both as a 
percentage of total health expenditure and per capita. Better data are urgently needed, given 
that a lack of sustainable, long-term funding may be the most significant barrier to public 
health programmes and interventions in Europe.  
Conclusions: In view of the current economic crisis, it will be essential to safeguard 
financing for public health and to put it on a more sustainable basis. 
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Zusammenfassung 
Ziel: Die Höhe und Mechanismen der Finanzierung öffentlicher Gesundheit in Europa 
festzustellen. 
Methodik: Auswertung veröffentlichter und unveröffentlichter Literatur und Analyse von 
Gesundheitsausgaben. 
Ergebnisse: Ausgaben zur öffentlichen Gesundheit in Europa lassen sich nicht zweifelsfrei 
ermitteln, aber, gemäß vorliegender nationaler Gesundheitskonten, variieren stark zwischen 
Ländern, sowohl als Anteil von Gesamtgesundheitsausgaben, als auch pro Kopf. 
Verlässlichere Daten sind dringend erforderlich, da das Fehlen einer nachhaltigen und 
langfristigen Finanzierung die größte Herausforderung von Programmen zur öffentlichen 
Gesundheit in Europa zu sein scheint.   
Schlussfolgerung: Im Hinblick auf die gegenwärtige Wirtschaftskrise ist es wichtig, die 
Finanzierung von Programmen zur öffentlichen Gesundheit sicherzustellen und auf eine 
nachhaltigere Grundlage zu stellen. 
 
Schlüsselwörter: öffentliche Gesundheit, Ausgaben, Finanzierung, Europa 
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Introduction 
The financing of public health has been described as something of a “black box” [1]. 
Research on health financing generally focuses on the financing of acute care and much 
less attention has been paid to how public health activities in Europe are being financed. 
One major reason for this may be the fact that expenditure on public health is difficult to 
capture, as much relevant action takes place outside the health system. The multiplicity of 
actors is another challenge, as is the fact that some costs (such as for occupational health) 
are often poorly accounted for [2]. This paper aims to shed light on the levels and 
mechanisms of funding public health in the WHO European region. 
Methods 
We conducted a documentary analysis of English-language sources relevant to the financing 
of public health operations in the WHO European region in April 2012. We reviewed two 
main types of documents. The first were sources available in the public domain. These 
included: 
 the Health Systems in Transition (HiT) country profiles of the European Observatory 
on Health Systems and Policies [available at: http://www.euro.who.int/en/who-we-
are/partners/observatory/health-systems-in-transition-hit-series]; 
 self-assessments of public health capacities and services undertaken by WHO 
member states, supported by the WHO Regional Office for Europe and using a self-
assessment tool structured around 10 essential public health operations (EPHOs). At 
the time of writing (April 2012), such assessments had been published in English on 
Estonia, Uzbekistan and South Eastern Europe; 
 data on expenditure on public health and prevention published by WHO; 
 articles published in international peer-reviewed journals and indexed on 
PubMed/Medline; in our search of article titles we combined three concepts, one 
related to public health (using the search terms “public health” OR “prevention” OR 
“health promotion”), one related to financing (using the search terms “fund*” OR 
“finance*” OR “pay*” OR “allocate*” OR “expenditure”), and one related to the 
geographical region (using the search terms “Europe*” OR “EU” OR the country 
names of the WHO European region). We excluded publications that did not deal 
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with the financing of public health in Europe, were published before 2005, were not in 
English or did not contain an abstract.  
The second type of documents were not available in the public domain. These included: 
 an ongoing study on facets of public health by the European Observatory on Health 
Systems and Policies that will be published in 2013 [3]; 
 unpublished or draft self-assessments of public health capacities and services 
undertaken by WHO member states and written in English; these were provided to us 
by the WHO Regional Office for Bulgaria, Bosnia and Herzegovina, Croatia, 
Macedonia, Romania and Slovenia; 
 the final report for an EU-funded study of public health capacity in the European 
Union, led by Maastricht University, that is envisaged to be published later in 2013; 
the study was based on information provided by key informants, complemented by 
focus group discussions of experts in each of the EU member states [4]. 
Findings 
Several key dimensions of financing public health emerged. We will consider the expenditure 
devoted to public health and the mechanisms for funding public health activities in turn.  
Expenditure on public health 
As mentioned above, it is challenging to ascertain how much is spent on public health, due 
to the multiplicity of actors and sectors. In addition, until recently, the very definition of public 
health activities used to differ not only from one country to the next, but even between 
OECD, WHO and Eurostat [2, 5]. Some definitions included personal health services 
delivered by public health agencies, while others only included population-based services 
[5]. As a result, in 2010, data on expenditure on prevention and public health in Europe 
differed between OECD [6] and Eurostat [7].  
Only in 2011 has a global standard of national health accounts been published [8]. For the 
first time, detailed guidance is available on what should and should not be included, based 
on explicit criteria. Prevention and public health services are defined as “services designed 
to enhance the health status of the population as distinct from curative services, which repair 
health dysfunction”. Sub-components include maternal and child health, school health 
services, prevention of communicable or non-communicable diseases, and occupational 
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health care. While this clarifies the boundaries considerably, and explicitly includes areas 
such as environmental surveillance for public health purposes, there are many areas that, in 
some countries, may come within the remit of public health, such as strategies to improve 
health through active transport programmes, that fall outside them [9].  
Notwithstanding these limitations, available data from national health accounts provide the 
best possible estimates for internationally comparable national health expenditure. They are 
based on national reporting and published in the WHO Global Health Expenditure database. 
Where adjustments or estimates are required, these are validated by national Ministries of 
Health prior to publication [10].  
Health accounts for the countries of the WHO European region indicate that expenditure on 
prevention and public health differs greatly as a percentage of total health expenditure 
(Table 1), ranging in 2010 from an implausible 0.62% in Italy to 8.17% in Romania [11]. This 
suggests considerable room for increased financial allocations to public health in many 
European countries, but also that some data (such as for the extremes Italy or Romania) 
may not be entirely accurate. Unsurprisingly, in the study on public health capacity in the EU, 
the lack of adequate resource provision was identified as often the most significant barrier to 
the effective implementation of public health programmes and interventions [4]. 
 
[Table 1 around here] 
 
It is also important to note that levels of total health expenditure per capita differ markedly 
across Europe. In per capita terms, and adjusted for purchasing power parity (PPP), 
expenditure on prevention and public health in 2010 differed by a factor of more than 50, 
from US$ 3.6 in Tajikistan to US$ 193.8 in the Netherlands (Table 2). However, it is 
important to note that factors for calculating Purchasing Power Parity focus on internationally 
traded goods; these corrections must thus be interpreted with care [12].  
 
[Table 2 around here] 
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Mechanisms for financing public health in Europe 
Just as with the financing of health care in general, arrangements for financing public health 
vary greatly within Europe. An overview of the main mechanisms, as well as illustrative 
examples, is given below. 
Funding mechanisms 
Many public health activities are linked to the health care system and are influenced by the 
way that these are financed. Consequently, they vary between systems funded from taxation 
and social insurance and, when tax-based, which administrative level pays for public health 
activities. It has been suggested that countries with social health insurance models of 
funding have less comprehensive national public health activities than those with tax-based 
systems, due to the more population-oriented approach of the former [2]. However, financing 
arrangements are much more complex than this dichotomy suggests and also differ 
according to the type of activity.  
In some countries, such as France [13], the multiplicity of funding sources was noted as a 
weakness confronting disease prevention and health promotion activities. Unstable funding 
was also noted in the countries of South Eastern Europe, where funding is often allocated on 
an ad hoc basis, sometimes relying on international agencies, leading to haphazard planning 
and a lack of overall strategies [14]. A disconnect with outputs has been identified as another 
weakness [15]. 
While in some countries with health insurance funds, these funds support public health 
activities, often the public health function is funded separately, from taxation. Germany is an 
example of the former. Most preventive measures aimed at individuals, such as 
immunizations, screening programmes and health check-ups are carried out by office-based 
physicians and included in the sickness funds’ benefit package, which also cover population-
based health promotion activities [16]. In Croatia too, the national vaccination programme is 
completely covered by the Health Insurance Institute [17]. 
In contrast, the Netherlands, which like Germany largely relies on health insurance to pay for 
curative health services, funds major prevention programmes from general taxation [18]. The 
countries of central and eastern Europe and the former Soviet Union also use tax-based 
budgetary funding to fund public health services [19], with few significant reforms since the 
fall of communism [1]. However, even in these countries a mix of public financing sources 
seems to be common, such as in the Czech Republic, where preventive services provided 
by GPs (vaccinations and screening) are covered by the benefit package of the health 
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insurance fund, while the Ministry of Health provides direct, tax-based funding for public 
health services, such as specialized health programmes [20]. Austria also relies on a mix of 
financing sources; the two-thirds of the budget for vaccines is from the federal government, 
and a sixth each is paid each by the Länder (regions) and the social health insurance 
institutions [21]. In south-eastern Europe, funding for core public health functions, such as 
vaccination, typically comes directly from central government [14]. 
Those countries with tax-based funding for public health activities differ with regard to which 
level of government is involved. In general, this follows constitutional arrangements, with 
sub-national levels playing an important financing role in federal systems, with implications 
for geographical equity. However, responsibilities are often shared. In Finland, for example, 
municipalities are responsible for funding immunizations [22]. In Denmark, vaccination 
programmes are also financed by the regions [23], while in Belgium two thirds of vaccination 
costs are borne by the federal government and one third by the communities [24]. In almost 
all countries of central and eastern Europe and the former Soviet Union, tax-based funding 
comes from the central government, but there are exceptions, such as Poland, which has 
introduced co-funding from the local government [19]. The “Öffentliche Gesundheitsdienst” in 
Germany is a state-run system of public health offices run and funded by cities and 
municipalities. However, capacity is often limited as a consequence of budgetary shortfalls in 
some cities and municipalities [4].  
Mechanisms for reimbursing providers 
In many European countries (including Austria, the Netherlands, Denmark, the Czech 
Republic, and the United Kingdom), payment of primary health care providers involves a 
mixed system, including, in varying combinations, the number of registered patients 
(capitation), fee-for-service, payment for implementation of certain programmes, and 
payment for performance [25, 26]. Performance or programme-based payment may involve 
targets, some of which may be related to public health activities. In Sweden for example, 
some county councils use a small performance-based element of payment (2-3% of the total 
payment), that is partly dependent on the provision of preventive services [27]. In South East 
Europe, several countries have adopted such combined payment systems [28]. In 
Montenegro, 10% of earnings of primary health care teams are directly related to 
implementing prevention programmes [29]. One model that has attracted much interest is 
the Quality and Outcomes Framework introduced for family medicine in the United Kingdom 
in 2004 [25]. This framework allocates extra funds to general practices if they meet a range 
of criteria, some of which relate to disease prevention [30]. In Estonia, GPs receive specific 
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incentives to offer preventive services, including counselling patients on medical and 
behavioural risks [31, 32]. While in some countries, personal preventive services are 
covered by the main public financing body, as in Estonia by the national health insurance 
fund [32], in others, such as Armenia [33], there are no incentives for physicians to engage 
in prevention.  
Financing health promotion 
The challenge of putting health promotion activities on a sustainable financial basis has been 
noted in several countries. The problem is particularly acute where funding mechanisms are 
not linked to health financing as a whole, but rather ad hoc or based on external funding [14, 
34]. Several countries, including Austria and Switzerland, have established foundations for 
health promotion [35, 36]. Both foundations pursue co-financing, which may have increased 
health promotion expenditure from other sectors [36]. Some of the most successful health 
promotion activities have been implemented in the Nordic countries [37], such as the often-
cited North Karelia project in Finland [22]. In Central and Eastern Europe, health promotion 
was underdeveloped in the Soviet period [35] and health promotion tends remain in many 
countries one of the most underdeveloped and underfinanced domains of public health [38]. 
Ear-marked taxes 
Some countries have started to ear-mark the revenue derived from taxes on products 
detrimental to health for public health activities. An example is Austria, where revenue from 
tobacco tax has to be used for preventive check-ups and health promotion measures [21]. 
Bulgaria has committed to devoting 1% of resources received in the national budget from 
excise duties on tobacco and alcoholic beverages are used for programmes addressing 
these risk factors and illicit drugs [14]. With the exception of taxes on tobacco and alcohol, 
however, the use of fiscal instruments for public health is not yet widespread [39].  
Responding to the economic crisis 
As a result of the current economic crisis, the financing of public health is in danger in many 
countries, as the long-term benefits of public health interventions are often overlooked [40]. 
Many structures for delivering public health operations in Europe are already facing 
substantial cutbacks and public health programmes and interventions in several countries, 
including Bulgaria, Latvia and the United Kingdom, have been scaled down [4]. One extreme 
example is Latvia, where, until 2009, the lead organization for public health was the Public 
Health Agency. In September 2009, it was closed down. In 2010, the government 
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discontinued provision of public health promotion activities to the population [4], although this 
is not yet reflected in expenditure data as shown in Table 1.  
Other countries have taken proactive action to sustain public health in times of crisis. The 
Austrian Health Promotion Foundation, for example, has since 2009 offered full financing to 
projects by small- and medium-sized companies, as these were perceived to be most 
affected by the economic crisis [36]. It is also noteworthy that the share of total health 
expenditure spent on public health has changed little in most countries in the years 2008-
2010 (Table 1).  
Discussion 
We hope our findings stimulate discussion about the need for more reliable information on 
levels and mechanisms for funding public health in Europe. While our review provided 
insights into what information is currently available, major gaps remain. The first is that 
available data on expenditure on public health is not entirely reliable. This has to do with 
definitional challenges, but also with the fact that not all public health activities are captured 
in national health accounts. To the degree that data exist, a large variation in expenditure on 
public health can be found, suggesting that the long-term benefits of investing in public 
health are still not widely accepted.  
There is also a large variation in mechanisms for funding public health. These are partly 
related to the way that political systems are decentralized, and sub-national levels play an 
important financing role in federal or decentralized systems. However, this carries the 
danger of exposing public health to different funding levels across sub-national units. 
Overall, there usually exists a mixture of funding sources, with no one best way of 
addressing this issue. Where many agencies are involved, the integration can become a 
challenge. One of the issues gaining increasing attention is the provision of public health 
activities by primary care physicians and nurses, which can be incentivized through different 
forms of bonus systems.  
The financing of health promotion activities is another area gaining attention, especially with 
regard to sustainable, long-term funding. A promising model seems to be the establishment 
of foundations for health promotion, which seem to improve sustainability and intersectoral 
revenue collection. Some countries are also leading the way with ear-marked taxes for 
public health activities, but, overall, and with the exception of alcohol and tobacco, the use of 
fiscal instruments for public health is not yet widespread. 
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Finally, the impact of the global economic crisis on funding public health is beginning to be 
felt. In some countries, such as Latvia, public health has almost completely been dismantled. 
Other countries are facing severe budget cutbacks. A key finding is that the available data 
indicate that the share of total health expenditure spent on public health has not declined 
since 2008. This suggests that, where the political will exists, funding for public health can be 
maintained and even increased. It will be essential to continue monitoring of expenditure on 
public health, as newer data become available. It will also be important to place a higher 
priority on publishing data in a timely manner; it seems strange, in a rapidly moving global 
environment, to be making decisions on data that are almost three years out of date.  
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Table 1 Expenditure on prevention and public health as % of total health 
expenditure, WHO European region, 2003-2010 
 
2003 2004 2005 2006 2007 2008 2009 2010 
Albania 1.57 
   
4.86 2.85 2.66 3.00 
Armenia 0.61 0.90 3.86 5.15 3.90 4.47 4.69 
 
Austria 1.77 2.02 1.91 1.90 1.91 1.76 1.68 1.68 
Belarus 
       
3.81 
Belgium 2.27 2.26 2.16 2.36 2.73 3.16 2.74 2.74 
Bosnia and 
Herzegovina  
2.70 2.69 2.67 2.35 2.63 1.86 2.43 
Bulgaria 3.45 3.86 3.01 3.45 3.86 4.10 3.46 3.46 
Croatia 0.00 0.00 0.00 0.00 0.00 0.00 0.65 0.68 
Cyprus 0.58 0.55 0.55 0.61 0.64 0.64 0.69 0.71 
Czech Republic 1.68 1.96 1.67 2.08 2.19 2.59 2.60 2.60 
Denmark 2.26 2.20 2.12 2.02 0.89 0.92 2.16 2.16 
Estonia 2.19 1.97 2.31 2.54 2.70 2.71 2.32 2.90 
Finland 4.81 4.89 5.05 5.10 5.40 5.42 5.26 5.25 
France 2.02 2.04 1.97 1.95 1.98 1.96 2.15 2.15 
Georgia 2.20 2.27 1.80 1.12 1.15 0.64 1.20 1.61 
Germany 3.23 3.26 3.23 3.29 3.51 3.59 3.54 3.54 
Hungary 4.77 4.30 4.25 4.06 4.00 3.86 4.25 4.25 
Iceland 1.39 1.45 1.51 1.49 1.58 1.54 1.43 1.44 
Ireland 2.32 2.96 2.96 3.00 2.95 2.97 2.98 2.97 
Israel 0.92 0.85 0.77 0.70 0.65 0.66 0.66 0.64 
Italy 0.71 0.62 0.56 0.56 0.60 0.62 0.61 0.62 
Kyrgyzstan 
 
2.20 
 
2.38 2.97 4.73 4.07 4.06 
Latvia 2.73 0.98 0.25 2.86 1.40 1.43 2.90 2.90 
Lithuania 3.42 1.72 1.69 1.18 1.74 1.17 1.13 1.13 
Luxembourg 1.77 1.47 2.06 1.68 1.90 1.72 1.75 1.75 
Malta 1.59 1.52 1.43 1.33 1.45 1.13 1.32 1.33 
Montenegro 
 
0.57 0.56 0.68 
    
Netherlands 4.89 4.49 4.33 4.58 4.66 4.51 4.01 3.85 
Norway 1.93 1.94 1.91 1.90 1.99 2.07 
 
2.11 
Poland 3.30 1.68 2.28 2.31 2.22 2.19 2.14 2.14 
Portugal 1.97 1.89 1.94 1.66 1.66 1.79 1.80 1.80 
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Republic of 
Moldova       
4.35 7.56 
Romania 6.16 6.63 6.73 5.32 6.58 5.80 8.17 8.17 
Serbia 8.70 8.02 7.43 7.33 7.05 6.68 7.49 6.33 
Slovakia 1.64 2.73 2.28 4.29 4.71 4.61 4.62 4.61 
Slovenia 3.42 3.65 3.54 3.58 3.72 3.63 3.57 3.58 
Spain 2.23 2.25 2.27 2.29 2.37 2.27 2.58 2.58 
Sweden 3.10 3.06 3.29 3.07 3.34 3.45 3.64 3.63 
Switzerland 2.28 2.20 2.18 2.16 2.32 2.47 2.52 2.52 
Tajikistan 0.94 0.92 1.32 
 
2.19 3.03 2.78 2.84 
Turkey 4.67 5.11 4.97 4.91 5.38 5.57 5.54 5.54 
Ukraine 3.68 3.68 3.47 3.65 3.50 3.39 3.08 3.16 
Source: [11] 
Note: No data available for Andorra, Azerbaijan, Greece, Kazakhstan, Monaco, the Russian 
Federation, San Marino, Macedonia, Turkmenistan, United Kingdom and Uzbekistan. 
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Table 2 Expenditure on prevention and public health per capita at Purchasing 
Power Parity (National Currency Unit per US$), WHO European region, 2003-2010 
 
2003 2004 2005 2006 2007 2008 2009 2010 
Albania 5.1 
   
24.0 15.9 15.7 17.3 
Armenia 1.0 1.7 7.7 10.3 8.5 10.3 11.5 
 Austria 56.7 68.4 66.3 70.6 74.0 72.8 72.2 73.9 
Belarus 
       
30.0 
Belgium 69.0 71.4 69.7 77.4 93.8 117.4 108.4 110.5 
Bosnia and 
Herzegovina 
 
14.2 15.5 17.8 18.1 23.5 17.3 23.6 
Bulgaria 21.5 25.1 21.7 26.4 32.5 39.8 34.4 32.8 
Croatia 
      
10.1 10.3 
Cyprus 8.5 8.1 8.5 10.1 11.1 11.9 12.9 13.0 
Czech 
Republic 22.5 27.1 24.6 32.3 36.3 47.7 54.8 53.3 
Denmark 65.3 68.7 68.9 72.1 33.2 36.9 93.7 97.8 
Estonia 16.5 16.9 19.1 24.3 29.8 35.5 31.1 35.5 
Finland 108.4 119.8 130.8 141.0 157.3 171.2 169.6 172.4 
France 60.4 63.3 64.9 67.9 72.6 74.6 85.2 86.3 
Georgia 5.2 5.9 5.4 3.8 4.4 2.8 5.8 8.4 
Germany 100.0 103.4 108.7 117.5 130.8 142.1 149.4 153.4 
Hungary 61.2 56.2 60.0 60.3 57.3 57.7 64.2 62.4 
Iceland 45.3 49.1 51.2 50.2 55.3 56.2 51.3 47.1 
Ireland 58.9 81.8 87.1 95.2 102.4 112.0 112.1 109.9 
Israel 15.8 15.3 13.7 13.0 12.9 13.7 14.0 14.1 
Italy 16.1 14.7 14.0 15.2 16.5 18.7 18.8 18.7 
Kyrgyzstan 
 
2.1 
 
2.8 4.0 6.1 6.0 5.7 
Latvia 17.8 7.5 
 
29.0 16.7 17.0 30.9 31.7 
Lithuania 26.8 12.8 14.1 11.8 19.8 15.3 14.6 14.7 
Luxembourg 82.4 78.3 111.8 102.3 114.8 104.7 115.3 117.7 
Malta 26.2 26.9 28.1 27.3 29.4 23.6 28.2 30.1 
Montenegro 
 
3.8 4.0 5.8 
    Netherlands 151.6 148.7 149.6 169.6 183.8 190.9 195.8 193.8 
Norway 73.9 79.3 82.3 87.5 97.4 108.3 
 
114.6 
Poland 24.7 13.6 19.5 21.6 23.9 27.7 29.8 31.6 
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Portugal 37.3 37.7 43.0 38.2 40.2 44.9 48.3 50.7 
Republic of 
Moldova 
      
15.5 27.3 
Romania 25.2 31.8 34.8 30.2 44.1 47.2 66.9 66.3 
Serbia 53.1 54.0 57.4 65.1 73.8 79.5 87.1 74.0 
Slovakia 13.0 28.9 26.0 57.9 76.3 85.7 96.3 95.0 
Slovenia 60.4 67.7 69.9 75.2 78.9 88.6 91.0 91.4 
Spain 45.1 47.9 51.5 58.1 64.9 67.3 79.0 78.0 
Sweden 87.8 90.3 97.4 98.1 114.6 125.7 135.5 136.5 
Switzerland 85.3 85.9 86.7 91.0 105.2 120.9 128.6 135.9 
Tajikistan 0.5 0.5 1.0 
 
2.1 3.3 3.4 3.6 
Turkey 21.9 27.9 30.9 36.8 45.2 50.6 53.0 57.0 
Ukraine 11.5 12.8 12.5 14.6 15.6 16.5 15.2 16.4 
Source: Authors’ calculations, based on [11] 
Note: No data available for Andorra, Azerbaijan, Greece, Kazakhstan, Monaco, the Russian 
Federation, San Marino, Macedonia, Turkmenistan, United Kingdom and Uzbekistan. 
 
